Bragar Eagel & Squire, P.C. Files Securities Class Action Against Centene Corporation Following Stock Collapse.
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, has filed a securities class action lawsuit against Centene Corporation (NYSE: CNC) in the U.S. District Court for the Southern District of New York.
The complaint alleges that Centene misled investors about its financial outlook and key market indicators, ultimately causing substantial shareholder losses when the company abruptly slashed guidance.
The lawsuit covers investors who purchased or otherwise acquired Centene securities between December 12, 2024, and June 30, 2025, inclusive. The deadline to seek appointment as lead plaintiff is September 8, 2025.
According to the filed complaint, Centene executives gave the impression that the company had solid, reliable data supporting its projected revenue and membership growth. The company emphasized low morbidity rates and robust enrollment numbers across its Health Insurance Marketplace.
However, internal analysis told a different story.
Centene’s preliminary review of over two-thirds of its marketplace membership, spanning 22 states, revealed weaker-than-expected enrollment and elevated morbidity, undermining its previously confident financial guidance.
On July 1, 2025, Centene issued a press release withdrawing its full-year 2025 guidance. The company acknowledged that aggregate market performance had fallen short of projections and revised its adjusted earnings outlook to $1.8 billion and $2.75 in adjusted diluted EPS.
The financial markets responded swiftly and severely. Centene’s stock price fell more than 40% in one day, dropping from $56.65 to $44.78 per share on July 2, 2025. Investors lost billions in market capitalization virtually overnight.
The complaint alleges that Centene’s leadership violated federal securities laws by failing to disclose material facts and by issuing misleading public statements. Bragar Eagel & Squire, P.C. contends that had investors known the true enrollment and morbidity data during the Class Period, they would have made different investment decisions.
Investors who purchased Centene stock between December 12, 2024, and June 30, 2025, and experienced financial losses are encouraged to contact the firm to learn more about their legal options.
There is no cost or obligation to participate. Submit your claim here.
Contact Information
Investors seeking more information or wishing to join the case can contact:
-
Brandon Walker or Marion Passmore
-
(212) 355-4648
Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex securities litigation, corporate governance actions, and consumer class cases. With a strong track record of recoveries, the firm is dedicated to protecting shareholder rights and holding corporations accountable.
More Articles from Lawyer Monthly
-
Weil Advises on Superior’s $1.1B Deal with Oaktree Acquisition
-
Robbins Geller Files Class Action Against Rocket Pharmaceuticals
-
The Court of Public Opinion: Managing Reputation in Sex Crime Allegations
-
Wesley Snipes: The Hollywood Star Who Went to Prison for Tax Evasion
